Trade Wars & Tariffs

A new strategic partnership aims to deploy advanced surveillance and telecom tech across critical US sectors, combining manufacturing innovation with sales power.

As brands like She Said Yes champion lab-grown gems, consumers are embracing a new era of ethical, affordable luxury. What does this mean for tradition?

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

A Chinese startup's tiny new heart pump enters human trials, aiming to disrupt a billion-dollar market and solve a massive unmet need in cardiac care.

Ford hits the brakes on its aggressive EV plan, pivoting to profitable hybrids and a bold new venture in battery energy storage. What does this mean?

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

A new collaboration aims to transform market noise into actionable foresight, moving beyond simple bets to offer a unified view of the global economy.

SEG Solar's $80M Indonesian plant isn't just a new factory; it's a strategic move to build a non-FEOC solar supply chain for the United States.

AECOM's win on the GSA OASIS+ contract is more than a deal; it's a strategic move reshaping federal services and securing its role in national projects.

A massive USD 300M investment in a Quebec copper foil plant is set to eliminate a critical EV battery vulnerability for North America. Here's why.

Cerro de Pasco Resources locks in a vital community deal in Peru, a key step in a $400M plan to turn a century of mining waste into a profitable venture.

AMTD Digital's subsidiary is on a global hotel buying binge, but a history of extreme stock volatility and underlying financial risks raise serious questions.

Beyond software, a new accelerator offers hardware startups a rare advantage, bridging the gap from university labs to investor-ready prototypes.

A landmark green ammonia project in Spain offers a blueprint for industrial decarbonization, holding key strategic lessons for the biopharmaceutical sector.

VEON and Starlink's landmark satellite call in Kazakhstan isn't just a tech feat; it's an investment blueprint for the future of remote luxury.

California's Movandi is moving to Riyadh. A look at how sovereign incentives are building a new semiconductor hub and the wireless backbone for an AI future.

The safari park operator swung from a major loss to a $1.9M pre-tax profit, driven by revenue growth and the absence of prior-year proxy battle costs.

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

With a $157M expansion, Hyosung aims to build the USA's largest transformer plant, tackling an energy crisis fueled by AI and an aging infrastructure.

Aligos Therapeutics is using strategic stock grants to lure top talent. Is this a savvy growth play or a creeping cost for shareholders? We break it down.